Adjusting for Differential Rates of Prophylaxis Therapy for PCP in High-Versus Low-Dose AZT Treatment Arms in an AIDS Randomized Trial
causal inferencesemiparametric modelssurvival analysisdependent censoringintermediate variablestime-dependent covariatesdirect effectsacquired immunodeficiency syndromestructural nested failure time modelssurrogate markersrandomized trialsG-estimationG-computation algorithmmedian survival3-azido- 3-deoxythymidineAIDS clinical trial groupcounterfactual variableshigh- dose AZT armlow-dose AZTnon-random non-compliancepneumocystis carinii pseumoniaprophylaxis therapy
- Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank Tests
- Marginal Structural Models to Estimate the Joint Causal Effect of Nonrandomized Treatments
- Modeling the Relationship of Survival to Longitudinal Data Measured with Error. Applications to Survival and CD4 Counts in Patients with AIDS
- Comparing the survival of two groups with an intermediate clinical event
- An analytic method for randomized trials with informative censoring. II
- Structural nested models and G-estimation: the partially realized promise
- Principal stratification in causal inference
- Defining and estimating intervention effects for groups that will develop an auxiliary outcome
- Causal Mediation Analyses with Rank Preserving Models
- Comparing the survival of two groups with an intermediate clinical event
- Proportional hazards models based on biased samples and estimated selection probabilities
- Compliance subsampling designs for comparative research: estimation and optimal planning
- Stratified Analysis in Randomized Trials with Noncompliance
- Confounding and collapsibility in causal inference
- Assessing HIV-infected patient retention in a program of differentiated care in sub-Saharan Africa: a G-estimation approach
- Estimation of direct effects for survival data by using the Aalen additive hazards model
- Bounds on the complier average causal effect in randomized trials with noncompliance
- Structural Cumulative Survival Models for Estimation of Treatment Effects Accounting for Treatment Switching in Randomized Experiments
- Sensitivity analysis for subsequent treatments in confirmatory oncology clinical trials: A two‐stage stochastic dynamic treatment regime approach
- Addressing an idiosyncrasy in estimating survival curves using double sampling in the presence of self-selected right censoring
- Synthesizing studies for comparing different treatment sequences in clinical trials
- A Review of Spatial Causal Inference Methods for Environmental and Epidemiological Applications
- Estimating optimal dynamic treatment regimes with survival outcomes
- Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank Tests
- An approach for estimating causal effects in randomized trials with noncompliance
- Related Causal Frameworks for Surrogate Outcomes
- Estimating Cumulative Treatment Effects in the Presence of Nonproportional Hazards
This page was built for publication: Adjusting for Differential Rates of Prophylaxis Therapy for PCP in High-Versus Low-Dose AZT Treatment Arms in an AIDS Randomized Trial
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4314944)
